FLUOCINOLONE ACETONIDE
Information current as at: 1 April 2025
The pharmaceutical company has advised that it is not proceeding in the PBS listing process at this time. The process for listing this medicine has ceased.
Submission Details
- Brand name:
-
- Iluvien®
- Pharmaceutical company:
- Specialised Therapeutics Pharma Pty Ltd
- Condition/indication:
(therapeutic use) -
- Diabetic macular oedema
- PBAC Submission type:
- New listing (Major)
- Comment:
- --
- Public Summary Document:
- PBAC Public Summary Documents – March 2020
- Related medicines:
- --
Progress Details
-
Submission received for: - March 2020 PBAC meeting
-
Opportunity for consumer comment: - Open 24/12/2019 and close 12/02/2020 (see PBS Website)
-
PBAC meeting: - Held on 11/03/2020
-
PBAC outcome published: - Recommended (see PBAC Outcomes)
-
Notice of intent submitted:
- Awaiting lodgement from pharmaceutical company
-
Lodgement of required documentation: - Not applicable
-
Agreement to listing arrangements: - Not applicable
-
Government processes: - Not applicable
-
Medicine listed on the PBS: - Not applicable
Case ID: a129
Page last updated: 31 October 2024